Daclizumab (Zenapax) is a humanized monoclonal antibody that specifically inhibits the alpha subunit of IL-2R-HA. Daclizumab (Zenapax) can inhibit the binding of IL-2 and IL-2R-HA through specific binding to CD25. Daclizumab (Zenapax) studies multiple sclerosis.
Purity:
100.00%
CAS Number:
[152923-56-3]
Target:
Interleukin|||IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted